Jackie Bosch

Population Health Research Institute
Canada

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 70 Citations 37,326 217 World Ranking 17314 National Ranking 719

Overview

What are the main themes of his work throughout his whole career to date

As part of his studies on Internal medicine, Jackie Bosch often connects relevant subjects like Adverse effect. In his works, Jackie Bosch undertakes multidisciplinary study on Confidence interval and Hazard ratio. In his research, Jackie Bosch performs multidisciplinary study on Hazard ratio and Confidence interval. Jackie Bosch integrates Pathology and Cardiology in his studies. Jackie Bosch integrates Cardiology and Pathology in his research. Jackie Bosch combines Placebo and Alternative medicine in his research. Alternative medicine is closely attributed to Digit symbol substitution test in his research. His Digit symbol substitution test study often links to related topics such as Placebo. Jackie Bosch merges many fields, such as Hydrochlorothiazide and Candesartan, in his writings.

Jackie Bosch most often published in these fields:

Internal medicine (100.00%)
Confidence interval (100.00%)
Pathology (50.00%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Effects of an angiotensin-converting -enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

S Yusuf;P Sleight;J Pogue.
The New England Journal of Medicine (2000)

8140 Citations

Vitamin E supplementation and cardiovascular events in high-risk patients.

Yusuf S;Dagenais G;Pogue J;Bosch J.
The New England Journal of Medicine (2000)

2469 Citations

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.

rosiglitazone Medication Trial Investigators;H C Gerstein;S Yusuf.
The Lancet (2006)

2352 Citations

Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial

J.F.E Mann;H.C Gerstein;J Pogue;J Bosch.
Annals of Internal Medicine (2001)

1768 Citations

Basal insulin and cardiovascular and other outcomes in dysglycemia

Origin Trial Investigators;Hertzel C Gerstein;Jackie Bosch;Gilles R Dagenais.
The New England Journal of Medicine (2012)

1765 Citations

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

John W. Eikelboom;Stuart J. Connolly;Jackie Bosch;Gilles R. Dagenais.
The New England Journal of Medicine (2017)

1751 Citations

Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.

Eva Lonn;Jackie Bosch;Salim Yusuf;Patrick Sheridan.
JAMA (2005)

1342 Citations

Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE).

Eva M. Lonn;Salim Yusuf;Vladimir Dzavik;C. Ian Doris.
Circulation (2001)

1025 Citations

Surgical resection of hepatocellular carcinoma in cirrhotic patients: Prognostic value of preoperative portal pressure

J Bruix;A Castells;J Bosch;F Feu.
Gastroenterology (1996)

1020 Citations

Effect of ramipril on the incidence of diabetes.

Jackie Bosch;Salim Yusuf;Hertzel C Gerstein.
The New England Journal of Medicine (2006)

969 Citations

If you think any of the details on this page are incorrect, let us know.